377 related articles for article (PubMed ID: 22300101)
1. Agonist replacement therapy for cocaine dependence: a translational review.
Rush CR; Stoops WW
Future Med Chem; 2012 Feb; 4(2):245-65. PubMed ID: 22300101
[TBL] [Abstract][Full Text] [Related]
2. Agonist replacement for stimulant dependence: a review of clinical research.
Stoops WW; Rush CR
Curr Pharm Des; 2013; 19(40):7026-35. PubMed ID: 23574440
[TBL] [Abstract][Full Text] [Related]
3. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
Rush CR; Stoops WW; Hays LR
Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
[TBL] [Abstract][Full Text] [Related]
4. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Jordan CJ; Cao J; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
[TBL] [Abstract][Full Text] [Related]
5. Psychostimulant treatment of cocaine dependence.
Mariani JJ; Levin FR
Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
[TBL] [Abstract][Full Text] [Related]
6. Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
Negus SS; Mello NK; Blough BE; Baumann MH; Rothman RB
J Pharmacol Exp Ther; 2007 Feb; 320(2):627-36. PubMed ID: 17071819
[TBL] [Abstract][Full Text] [Related]
7. Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.
Bolin BL; Stoops WW; Sites JP; Rush CR
J Addict Med; 2016; 10(3):156-65. PubMed ID: 26933876
[TBL] [Abstract][Full Text] [Related]
8. Agents in development for the management of cocaine abuse.
Gorelick DA; Gardner EL; Xi ZX
Drugs; 2004; 64(14):1547-73. PubMed ID: 15233592
[TBL] [Abstract][Full Text] [Related]
9. Cocaine choice in humans during D-amphetamine maintenance.
Rush CR; Stoops WW; Sevak RJ; Hays LR
J Clin Psychopharmacol; 2010 Apr; 30(2):152-9. PubMed ID: 20520288
[TBL] [Abstract][Full Text] [Related]
10. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.
Grabowski J; Shearer J; Merrill J; Negus SS
Addict Behav; 2004 Sep; 29(7):1439-64. PubMed ID: 15345275
[TBL] [Abstract][Full Text] [Related]
11. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
[TBL] [Abstract][Full Text] [Related]
12. Replacement medication for cocaine dependence: methylphenidate.
Grabowski J; Roache JD; Schmitz JM; Rhoades H; Creson D; Korszun A
J Clin Psychopharmacol; 1997 Dec; 17(6):485-8. PubMed ID: 9408812
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of dual substance abuse and dependence.
Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
[TBL] [Abstract][Full Text] [Related]
14. New treatments for cocaine dependence: a focused review.
Karila L; Gorelick D; Weinstein A; Noble F; Benyamina A; Coscas S; Blecha L; Lowenstein W; Martinot JL; Reynaud M; Lépine JP
Int J Neuropsychopharmacol; 2008 May; 11(3):425-38. PubMed ID: 17927843
[TBL] [Abstract][Full Text] [Related]
15. The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates.
Howell LL; Wilcox KM
J Pharmacol Exp Ther; 2001 Jul; 298(1):1-6. PubMed ID: 11408518
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatments for cocaine dependence: is there something new?
Karila L; Reynaud M; Aubin HJ; Rolland B; Guardia D; Cottencin O; Benyamina A
Curr Pharm Des; 2011; 17(14):1359-68. PubMed ID: 21524259
[TBL] [Abstract][Full Text] [Related]
17. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys.
Kohut SJ; Jacobs DS; Rothman RB; Partilla JS; Bergman J; Blough BE
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3455-3465. PubMed ID: 28889212
[TBL] [Abstract][Full Text] [Related]
18. Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys.
Kohut SJ; Bergman J; Blough BE
Psychopharmacology (Berl); 2016 Mar; 233(6):1067-75. PubMed ID: 26713332
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys.
Negus SS; Mello NK
Drug Alcohol Depend; 2003 May; 70(1):39-52. PubMed ID: 12681524
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys.
Czoty PW; Blough BE; Fennell TR; Snyder RW; Nader MA
Neuroscience; 2016 Jun; 324():367-76. PubMed ID: 26964683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
